Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.
Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
Trump administration scrambles to rehire key fired workers (again)
DOGE reportedly fired members of the FDA’s cardiac devices unit, which oversees devices like pacemakers and implantable defibrillators.
Deadly listeria outbreak linked to shakes used at nursing homes, hospitals. Florida impact
The supplement shakes were sold to hospitals and long-term care facilities, including nursing homes. There is a nationwide ...
Hosted on MSN1h
Scarborough slams DOGE layoffs for making red states 'suffer'
Many right-wing media pundits are applauding President Donald Trump and the Elon Musk-led Department of Government Efficiency ...
What is metformin, the old diabetes drug some people are taking for weight loss?
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen
Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...
fox13now1h
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
MyNorthwest.com3h
The Latest: Musk renews threat to fire federal workers despite pushback from various agencies
Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
Hims & Hers shares drop on doubts over weight-loss business forecast
Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's lofty sales forecast in the face of looming restrictions on compounded weight ...